Coronavirus Bear Market: All Stocks Are Under Quarantine, But Keep Vertex, Biogen, Dexcom, Eli Lilly, Masimo Under Observation [Investor's Business Daily]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Investors Business Daily
Related news 3/13/2020 Even with the nearly 9% weekly fall for the S&P 500, many of the Long-Term Leaders fell in line with... Stocks Get Bear Market Bounce: Masimo, Adobe Hold Up, Tesla Reverses Why This IBD Stock Of The Day Is Outlasting The Coronavirus Correction These Are The 5 Best Stocks To Buy And Watch Now Biotech Stocks To Watch And Pharma Industry News IBD Stock Of The Day Stocks Trade Near Lowest Levels Of Session As Gains Thin Out When To Buy Large Cap Stocks During A Stock Market Crash: These 2 Sectors Offer Clues This Medical Giant Was Socked In February — Is Its Stock A Safe Bet? Investors should consider stocks under quarantine during the coronavirus bear market. But several health care stocks are worth considering for watchlists when a new stock market rally takes hold. Masimo ( MASI ), Eli Lilly ( LLY ), Biogen ( BIIB ), Dexcom ( DXCM ) and Vertex Pharmaceuticals ( VRTX ) These health care stocks are not directly relat
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- CEOs and celebrities love Oura's sleep-tracking ring. Its CEO has a plan to stay ahead of Apple and Google [CNN]CNN
- DexCom (NASDAQ:DXCM) had its price target raised by analysts at Mizuho from $75.00 to $78.00. They now have an "outperform" rating on the stock.MarketBeat
- CEOs and celebrities love Oura's sleep-tracking ring. Its CEO has a plan to stay ahead of Apple and Google [CNN]CNN
- DexCom, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Investors of Deadline in Securities Fraud Class Action LawsuitGlobeNewswire
- DXCM DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important December 29 Deadline in Securities Class Action – DXCMGlobeNewswire
DXCM
Earnings
- 10/30/25 - Beat
DXCM
Sec Filings
- 11/17/25 - Form 4
- 11/14/25 - Form 144
- 11/12/25 - Form 4
- DXCM's page on the SEC website